Processa Pharmaceuticals, Inc. Loans Payable, Current
Processa Pharmaceuticals, Inc. (PCSA) had Loans Payable, Current of $44.81 thousand as of 2015-09-30, per its 10-Q filed 2015-12-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Loans Payable, Current
us-gaap:LoansPayableCurrent · last filed 2017-06-19
- 2015-09-30: Loans Payable, Current $44.81K.
- 2015-06-30: Loans Payable, Current $57.34K.
- 2015-03-31: Loans Payable, Current $56.91K.
- 2014-12-31: Loans Payable, Current $56.49K.
| Period end | Loans Payable, Current |
|---|---|
| 2015-09-30 | $44.81K 10-Q · filed 2015-12-01 |
| 2015-06-30 | $57.34K 10-Q · filed 2015-08-19 |
| 2015-03-31 | $56.91K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $56.49K 10-K · filed 2017-06-19 |
| 2014-09-30 | $54.77K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $44.29K 10-Q · filed 2014-08-19 |
| 2014-03-31 | $41.57K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $41.19K 10-K · filed 2015-04-14 |
| 2013-09-30 | $40.34K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $27.58K 10-Q/A · filed 2013-09-06 |
| 2012-12-31 | $27.22K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |